RCM
BMY icon

Raleigh Capital Management’s Bristol-Myers Squibb BMY Stock Holding History

Raleigh Capital Management’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$37.4K Sell
649
-45
-6% -$2.58K 0.01% 298
2026
Q1 		$42.1K Buy
694
+131
+23% +$7.64K 0.01% 293
2025
Q4 		$30.4K Sell
563
-1,525
-73% -$73.4K 0.01% 320
2025
Q3 		$94.2K Sell
2,088
-672
-24% -$31.4K 0.04% 234
2025
Q2 		$128K Sell
2,760
-29,698
-91% -$1.46M 0.05% 224
2025
Q1 		$1.98M Sell
32,458
-6,981
-18% -$407K 0.9% 27
2024
Q4 		$2.23M Sell
39,439
-3,041
-7% -$170K 0.86% 24
2024
Q3 		$2.2M Buy
42,480
+12,705
+43% +$596K 0.85% 19
2024
Q2 		$1.24M Buy
29,775
+3,426
+13% +$153K 0.53% 58
2024
Q1 		$1.43M Buy
26,349
+22,383
+564% +$1.14M 0.62% 52
2023
Q4 		$203K Buy
3,966
+2,580
+186% +$135K 0.09% 185
2023
Q3 		$80.5K Sell
1,386
-10,646
-88% -$652K 0.04% 218
2023
Q2 		$769K Buy
12,032
+110
+0.9% +$7.38K 0.38% 82
2023
Q1 		$826K Buy
11,922
+1,541
+15% +$109K 0.41% 78
2022
Q4 		$747K Sell
10,381
-9,231
-47% -$696K 0.39% 78
2022
Q3 		$1.39M Sell
19,612
-1,954
-9% -$142K 0.82% 38
2022
Q2 		$1.66M Sell
21,566
-415
-2% -$31.6K 0.94% 30
2022
Q1 		$1.6M Buy
21,981
+21,862
+18,371% +$1.47M 0.87% 32
2021
Q4 		$7K Buy
+119
New +$6.98K 0.01% 213

Other funds holding BMY

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
FWIA
Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
DLA
Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Raleigh Capital Management's BMY Position: Q2 2026 in Review

Raleigh Capital Management reduced its Bristol-Myers Squibb (BMY) stake by 6.5% in Q2 2026, selling an estimated $2.58K and leaving 649 shares worth $37.4K. The position accounts for 0.01% of the portfolio, ranked #298.

Raleigh Capital Management first reported a position in BMY in Q4 2021 and has held it in 19 quarters since. The position peaked at $2.23M in Q4 2024. 706 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Raleigh Capital Management held 649 shares of Bristol-Myers Squibb worth $37.4K as of Q2 2026.
  • Raleigh Capital Management sold 45 Bristol-Myers Squibb shares in Q2 2026, an estimated $2.58K.
  • Bristol-Myers Squibb made up 0.01% of Raleigh Capital Management's portfolio in Q2 2026, its #298 holding.
  • Raleigh Capital Management first reported a position in Bristol-Myers Squibb in Q4 2021 and has held it in 19 quarters since.
  • Raleigh Capital Management's Bristol-Myers Squibb position peaked at $2.23M in Q4 2024.
  • 706 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Raleigh Capital Management's 13F filing for Q2 2026, filed 21 Jul 2026.